PEMT and cancer: The present study shows that in patients with resectable NSCLC, elevated PEMT expression in the cancer tissue (relative to the adjacent non-cancer lung tissue) predicts shorter survival, independently of standard prognostic factors and also independently of increased FASN or LPL activities in the cancer tissue.